

Axcellerate Pharma Revenue
Pharmaceutical Manufacturing • xxxxxxx xxxxx, xxxxx, United States • 1-10 Employees
Axcellerate Pharma revenue & valuation
| Annual revenue | $8,860,511 |
| Revenue per employee | $2,954,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $28,400,000 |
| Total funding | No funding |
Key Contact at Axcellerate Pharma
Ashwin A. Mehta
Director
Company overview
| Headquarters | xxxxxxx xxxxx, xxxxx, United States |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Lyophilization, Oncology, Biologics, Syringes, Oligonucleotides, Pegylation, Antibiotics....., Cartridges), Commercial Manufacturing (Vials, Cytotoxic, High Potency |
| Founded | 2013 |
| Employees | 1-10 |
| Socials |
About Axcellerate Pharma
Axcellerate is an award winning contract development and manufacturing organization (CDMO) focused on the production of Generics and Biologics. Our integrated services include: • Mammalian cell line development • Upstream and downstream process development • Fermentation * Analytical development / testing • cGMP biomanufacturing • Aseptic fill/finish (vials, syringes, lyophilization) All development activities are performed with a focus on ease of scale up to cGMP so we can efficiently take your product from development through the clinic with the ultimate goal of commercial manufacturing. Axcellerate takes pride in using a collaborative approach with our customers and providing individualized service to each customer, which is evidenced by the many industry awards we have received. We are a Commercial Manufacturer, with facilities for Vials, Syringes, High Potency,. Cytotoxic, Hormones & Steroids, Cephalosporins, with isolated buildings for handling them and isolated filling lines respectively. Our Piscataway facility: Axcellerate Pharma provides contract manufacturing and research services for the biopharmaceutical Industry. It deploys a unique combination of assets and operational capabilities to provide high quality CMO/CRO services and is ideally positioned to manufacture early cGMP clinical supplies of drug substance and sterile drug product for both large and small molecules.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Axcellerate Pharma has never raised funding before.
Frequently asked questions
4.8
40,000 users



